|Oral rivaroxaban for symptomatic venous thromboembolism|
New England Journal of Medicine 363 (26), 2499-2510, 2010
|Safety of low-molecular-weight heparin in pregnancy: a systematic review|
BJ Sanson, AWA Lensing, MH Prins, JS Ginsberg, ZS Barkagan, ...
Thrombosis and haemostasis 81 (05), 668-672, 1999
|Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial|
SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ...
The Lancet 391 (10117), 219-229, 2018
|Fondaparinux for the treatment of superficial-vein thrombosis in the legs|
H Decousus, P Prandoni, P Mismetti, RM Bauersachs, Z Boda, B Brenner, ...
New England Journal of Medicine 363 (13), 1222-1232, 2010
|Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial|
SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ...
The Lancet 391 (10117), 205-218, 2018
|Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial|
GE Raskob, N van Es, A Segers, P Angchaisuksiri, D Oh, Z Boda, ...
The Lancet Haematology 3 (8), e379-e387, 2016
|Edoxaban for treatment of venous thromboembolism in patients with cancer|
N van Es, M Di Nisio, SM Bleker, A Segers, MF Mercuri, L Schwocho, ...
Thrombosis and haemostasis 114 (12), 1268-1276, 2015
|Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency|
É Ajzner, Á Schlammadinger, A Kerényi, Z Bereczky, É Katona, ...
Blood, The Journal of the American Society of Hematology 113 (3), 723-725, 2009
|Platelet factor XIII becomes active without the release of activation peptide during platelet activation|
L Muszbek, J Polgár, Z Boda
Thrombosis and haemostasis 70 (03), 282-285, 1993
|Comparison of PFA-100 closure time and template bleeding time of patients with inherited disorders causing defective platelet function|
A Kerényi, Á Schlammadinger, É Ajzner, I Szegedi, C Kiss, Z Pap, Z Boda, ...
Thrombosis research 96 (6), 487-492, 1999
|Plasma levels of beta-thromboglobulin and factor VIII-related antigen in diabetic children and adults|
K Rak, P Beck, M Udvardy, G Pfliegler, M Misz, Z Boda
Thrombosis Research 29 (2), 155-162, 1983
|Comparison of the O’Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand’s disease|
A Schlammadinger, A Kerenyi, L Muszbek, Z Boda
Thrombosis and haemostasis 84 (07), 88-92, 2000
|Cyclosporin treatment of a woman with acquired haemophilia due to factor VIII: C inhibitor.|
G Pfliegler, Z Boda, J Harsfalvi, M Flora-Nagy, B Sari, K Pecze, K Rak
Postgraduate Medical Journal 65 (764), 400-402, 1989
|Promotion of the crosslinking of fibrin and α2-antiplasmin by platelets|
Z Hevessy, G Haramura, Z Boda, M Udvardy, L Muszbek
Thrombosis and haemostasis 75 (01), 161-167, 1996
|Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity|
JN Mahlangu, KN Weldingh, SR Lentz, S Kaicker, FA Karim, T Matsushita, ...
Journal of Thrombosis and Haemostasis 13 (11), 1989-1998, 2015
|Low molecular weight heparin as thromboprophylaxis in familial thrombophilia during the whole period of pregnancy|
Z Boda, P Laszlo, L Rejto, I Tornai, G Pfliegler, G Blasko, K Rak
Thrombosis and haemostasis 75 (01), 128-128, 1996
|Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia|
A Janssens, F Rodeghiero, D Anderson, BH Chong, Z Boda, I Pabinger, ...
Annals of hematology 95 (7), 1077-1087, 2016
|Respective prognostic values of germinal center phenotype and early 18fluorodeoxyglucose-positron emission tomography scanning in previously untreated patients with diffuse …|
J Dupuis, P Gaulard, F Hemery, E Itti, C Gisselbrecht, A Rahmouni, ...
Haematologica 92 (6), 778-783, 2007
|Anti‐factor V auto‐antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding|
E Ajzner, I Balogh, G Haramura, Z Boda, K Kalmar, G Pfliegler, ...
Journal of Thrombosis and Haemostasis 1 (5), 943-949, 2003
|Edoxaban for long-term treatment of venous thromboembolism in cancer patients|
GE Raskob, H Buller, P Angchaisuksiri, D Oh, Z Boda, RM Lyons, JI Weitz, ...
Blood, The Journal of the American Society of Hematology 122 (21), 211-211, 2013